1. Barriers to Adoption of Technology

    Together with JDRF and The Leona M. and Harry B. Helmsley Charitable Trust, T1D Exchange hopes to better understand perceptions of access to and usage of diabetes-related technology such as insulin pumps and continuous glucose monitors (CGMs). The findings of this study will be published and used to inform design strategies and programs aimed at […]

    Read More
  1. You Told Glu: Retinopathy One of the Most Feared Complications

    Despite the daily burden of management in type 1 diabetes, many people worry about complications. In fact, in a Glu Question of the Day, out of 563 responders, nearly half (44%) reported that they think about complications always or frequently. One of the most feared complications can be the threat of losing your vision. What […]

    Read More
  2. How Wearing a Device Made Me Want to Cry!

      A personal story from T1D Exchange co-founder and executive director Dana Ball One year ago I received unexpected news that I had coronary artery disease and needed to have bypass surgery. I remember being told this news after six weeks of appointments, tests, and procedures that reminded me just how depressing and frustrating medical […]

    Read More
  3. You Told Glu! Retinopathy in the Glu Community

      Good News! In a Question of the Day, an overwhelming majority (81% of 477) Glu participants indicated that they have been screened for diabetic retinopathy at some point in the past. However, it is important to get screened regularly!   Getting Screened Out of 537 people polled in the Glu community, 33% (175) reported […]

    Read More
  1. A Day without My CGM: I Couldn’t Do It

    I couldn’t do it. I couldn’t go a day—wait, let’s be real here—more than four hours without my continuous glucose monitor (CGM). Why? Okay, maybe because I’m nearly eight months pregnant and knowing each single number is critical to not only my health, but my child’s, but holy moly I’m addicted to that info. I even […]

    Read More
  2. A Path to Research

    Hi everyone! My name is Claire Clendenen and I have recently joined T1D Exchange as a Quality Improvement Program Coordinator. I graduated from Providence College in 2016 with a degree in health policy and management and am excited to start a career where I can connect patients, families, providers, and industry in order to improve […]

    Read More
  3. Setting Sail: When Diabetes Blows Opportunity Your Way

    Life with type 1 diabetes has many challenges. The pokes, the tears, the carb counting, the prescriptions and supplies, the insurance hassles, the worrying—I could go on and on! Any parent of a child with T1D would gladly live without it all. But once in a while, diabetes gives us something back—something we may not […]

    Read More
  4. It Takes an Army…and a Village

    Dear Friends, 14,000 people just spent 5 days learning to be better researchers, clinicians, scientists, and innovators in diabetes This is my fifteenth consecutive year attending the American Diabetes Association’s Scientific Sessions (the largest diabetes event in the world) where more than 14,000 global leaders meet to learn, share, and experience cutting-edge research and technology, […]

    Read More
  5. Polyphotonix Offers An Innovative Vision for Treating Retinopathy

    Last fall, T1D Exchange held its 1st Annual Diabetes Innovation Challenge, an open competition seeking novel treatments for diabetes. The competition introduced our partners and collaborators from industry, academic research, other diabetes nonprofits, clinical partners and patient/caregiver community to over 60 groundbreaking diabetes therapies or technologies currently in development. One of these applicants, UK-based Polyphotonix, […]

    Read More